A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
published in: Lancet Infectious Diseases
date of publication: 2012-01-10
main subject: phase II clinical trial, Cytomegalovirus, placebo, vaccine
Cites articles 27
Date
Title
Article - wd:Q50976609